Policy | July 03, 2022
Time to move from ‘Volume’ to ‘Value’ leadership to capture global market, says Mandaviya
Govt committed to supporting pharma companies with industry-friendly policies
Govt committed to supporting pharma companies with industry-friendly policies
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Bringing next-gen cannabinoid therapeutics to cancer patients
Expanding diagnostics footprint in East India
Glenmark is the first company in India to market the innovative FDC of Indacaterol
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
Subscribe To Our Newsletter & Stay Updated
